Global Acne Market: Industry Analysis & Outlook (2017-2021)
Acne is defined as a chronic skin disorder in which the hair follicles become blocked and/or inflamed. There are several variants of acne and they range from mild to severe. The most common type of acne is acne vulgaris (vulgaris means common). Acne appears most often on the face, but can also be a nuisance on chest, back, and upper arms. Although usually not considered a dangerous medical condition, acne can cause psychological distress and even skin scarring. Teenagers are the most commonly affected group with around 85% of 16-18 year olds believed to have some form of acne. However, some people may suffer from acne well into their 30s and 40s even.
The global acne market is set to experience favorable growth driven by factors such as increasing youth population, upsurge in disposable income, rising health care expenditure and growing sedentary lifestyle. The major trends observed in this market include technological advancements, rising preference for minimally invasive procedures and increasing awareness programs about acne. However, the growth of this market is constrained by challenges such as entry of generic drugs, side effects of acne therapies and stringent regulations.
The report “Global Acne Market: Industry Analysis & Outlook (2017-2021)” analyses the development of the market, with focus on the US and European markets. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: Valeant Pharmaceuticals International, Inc., Reckitt Benckiser Group Plc., Allergan Plc. And GlaxoSmithKline Plc. are being profiled along with their key financials and strategies for growth.